SG Americas Securities LLC Has $882,000 Stock Holdings in iRhythm Technologies (NASDAQ:IRTC)

SG Americas Securities LLC boosted its holdings in shares of iRhythm Technologies (NASDAQ:IRTC) by 95.6% in the first quarter, according to its most recent filing with the SEC. The firm owned 8,427 shares of the company’s stock after acquiring an additional 4,119 shares during the period. SG Americas Securities LLC’s holdings in iRhythm Technologies were worth $882,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Van ECK Associates Corp grew its holdings in iRhythm Technologies by 41.3% during the 4th quarter. Van ECK Associates Corp now owns 554 shares of the company’s stock worth $50,000 after acquiring an additional 162 shares during the period. Raiffeisen Bank International AG acquired a new stake in iRhythm Technologies during the 4th quarter worth $60,000. Avanza Fonder AB acquired a new stake in iRhythm Technologies during the 1st quarter worth $123,000. SeaCrest Wealth Management LLC acquired a new stake in iRhythm Technologies during the 1st quarter worth $212,000. Finally, Xponance Inc. acquired a new stake in iRhythm Technologies during the 4th quarter worth $203,000.

Wall Street Analysts Forecast Growth

A number of analysts have commented on IRTC shares. Truist Financial lifted their target price on shares of iRhythm Technologies from $111.00 to $145.00 and gave the stock a “buy” rating in a report on Friday, February 21st. Needham & Company LLC upped their target price on shares of iRhythm Technologies from $138.00 to $151.00 and gave the company a “buy” rating in a research note on Friday, May 2nd. Morgan Stanley upped their target price on shares of iRhythm Technologies from $130.00 to $160.00 and gave the company an “overweight” rating in a research note on Wednesday, June 11th. The Goldman Sachs Group upped their target price on shares of iRhythm Technologies from $91.00 to $124.00 and gave the company a “neutral” rating in a research note on Monday, February 24th. Finally, Citigroup upped their target price on shares of iRhythm Technologies from $130.00 to $167.00 and gave the company a “buy” rating in a research note on Thursday, May 22nd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, iRhythm Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $136.45.

iRhythm Technologies Stock Up 0.4%

Shares of IRTC stock opened at $145.53 on Thursday. The firm has a fifty day moving average of $129.43 and a 200-day moving average of $110.91. The company has a quick ratio of 5.58, a current ratio of 5.71 and a debt-to-equity ratio of 7.47. iRhythm Technologies has a 12-month low of $55.92 and a 12-month high of $150.00. The company has a market capitalization of $4.65 billion, a price-to-earnings ratio of -46.35 and a beta of 1.40.

iRhythm Technologies (NASDAQ:IRTC) last issued its quarterly earnings data on Thursday, May 1st. The company reported ($0.95) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.89) by ($0.06). iRhythm Technologies had a negative return on equity of 101.04% and a negative net margin of 15.90%. The company had revenue of $158.68 million for the quarter, compared to the consensus estimate of $153.39 million. During the same period in the prior year, the company earned ($1.23) EPS. The firm’s revenue was up 20.3% on a year-over-year basis. As a group, equities research analysts predict that iRhythm Technologies will post -1.98 earnings per share for the current fiscal year.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.